Fingerprint
Dive into the research topics of 'Phase 1 study of combinatorial sorafenib, G-CSF, and plerixafor treatment in relapsed/refractory, FLT3-ITD-mutated acute myelogenous leukemia patients'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically